CNTA
Centessa Pharmaceuticals
CNTA
CNTA
103 hedge funds and large institutions have $1.74B invested in Centessa Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
7.92% more ownership
Funds ownership: 76.53% → 84.45% (+7.9%)
88% less call options, than puts
Call options by funds: $99K | Put options by funds: $848K
Holders
103
Holding in Top 10
6
Calls
$99K
Puts
$848K
Top Buyers
| 1 | +$43.5M | |
| 2 | +$37.6M | |
| 3 | +$34.1M | |
| 4 |
CC
Commodore Capital
New York
|
+$21.6M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$21.6M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$19.1M | |
| 3 | -$10.7M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$5.86M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.46M |